関連する実験動画
Updated: May 6, 2026

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.2K
子どもにおける拡張性心筋症の発生率,原因,結果
Jeffrey A Towbin1, April M Lowe, Steven D Colan
1Texas Children's Hospital, Baylor College of Medicine, Houston, USA.
JAMA
|October 19, 2006
まとめ
拡張性心筋病 (DCM) は子供に影響し,発症率は年齢,性別,人種によって異なります. 結果は,診断時の原因,年齢,心不全の状態に依存し,多くの症例は原因が不明である.
科学分野:
- ペディアトリック・カルディオロジー
- 心血管伝染病学 心血管伝染病学
- 心臓病の遺伝学について
背景:
- 拡張性心筋症 (DCM) は,小児における心臓移植の主な原因であるが,その流行病学と臨床経過は依然として十分に理解されていない.
- 小児の集団におけるDCMの明確な理解を確立することは,患者のアウトカムを改善し,治療戦略を導くために不可欠です.
研究 の 目的:
- 子どもにおけるDCMに関連した発生率,病因,結果,およびリスク要因を包括的に記述する.
- 小児DCMの詳細な疫学プロフィールを提供する.
主な方法:
- 89の小児心臓センターからの前向きな,人口ベースのコホートを使用した縦断的な研究で,三等医療センターからの遡及的なコホートで補完されました.
- 北米で18歳未満でDCMと診断された1426人の子供を含む,疾患の二次原因を除く.
- 主要なDCMは,厳格なエコーカルディオグラフィックおよび/または病理学的基準を使用して確認されました.
主要な成果:
- 小児性DCMの全年発生率は10万人に0.57であったが,男の子,黒人,および1歳未満の乳児ではより高い.
- Idiopathic DCMは66%の症例を占め,心筋炎と神経筋疾患が最も一般的な既知の原因でした.
- 1年および5年後の死亡率または心臓移植率はそれぞれ31%と46%でした. 副作用の危険因子には,高齢化,閉塞性心不全,左心室機能の低下などがある.
結論:
- 小児のDCMは,結果が根本的な原因,患者の年齢,心不全の発症時の重症度によって著しく影響される異質な状態です.
- 発生率は人種,性別,年齢によって影響を受け,人口格差を強調しています.
- イディオパシー症例の割合が高いことは,標的型療法を開発するための基礎的なメカニズムに関するさらなる研究が必要であることを強調しています.
関連する概念動画
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Cardiomyopathy I: Introduction and Classification
837
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy
968
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762

